Heterocyclic compounds as pesticides

1. A compound of the formula (I)

wherein

Z represents optionally substituted naphthyl, dibenzo[b,d]furanyl, dibenzo[b,d]thiophenyl, carbazolyl, indanyl, benzothiophenyl, benzofuranyl, indolyl, fluorenyl, phenanthrenyl, anthracenyl, or represents a phenyl of the substructure formula (II)

and the substituted phenyl of the substructure formula (II) may optionally carry up to two further substituents selected from the group consisting of halogen, cyano, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 3 -C 6 )-cycloalkyl, and (C 3 -C 6 )-halocycloalkyl,

Y represents O or S,

A 1 represents N or —CR 1 ,

A 2 represents N or —CR 2 ,

A 3 represents N or —CR 3 ,

A 4 represents N or —CR 4 ,

where at least one and at most two of the atoms A 1 , A 2 , A 3 and A 4 in the aromatic ring represents N,

X represents oxygen, sulfanyl, sulfinyl, sulfonyl, —CH 2 , carbonyl, —CHOH, or —NR 6 ,

R 1 , R 2 , R 3 and R 4 each independently of one another represent hydrogen, halogen, nitro, cyano, aminocarbonyl, or aminosulfonyl, in each case optionally substituted (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, N-mono-(C 1 -C 4 )-alkylamino, N-mono-(C 3 -C 6 )-cycloalkylamino, N,N-di-(C 1 -C 4 )-alkylamino, N,N-di-(C 3 -C 6 )-cycloalkylamino, N,N—(C 3 -C 6 )-cycloalkyl-(C 1 -C 4 )-alkylamino, N—(C 1 -C 4 )-alkanoylamino, N—(C 3 -C 6 )-cycloalkanoylamino, N—(C 1 -C 4 )-alkanoyl-N—(C 1 -C 4 )-alkylamino, N—(C 3 -C 6 )-cycloalkanoyl-N—(C 1 -C 4 )-alkylamino, N—(C 3 -C 6 )-cycloalkanoyl-N—(C 3 -C 6 )-cycloalkylamino, N—(C 1 -C 4 )-alkanoyl-N—(C 3 -C 6 )-cycloalkylamino, (C 1 -C 4 )-alkoxycarbonyl, (C 3 -C 6 )-cycloalkoxycarbonyl, (C 1 -C 4 )-alkanoyl, (C 3 -C 6 )-cycloalkanoyl, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 3 -C 6 )-cycloalkylsulfanyl, (C 3 -C 6 )-cycloalkylsulfinyl, (C 3 -C 6 )-cycloalkylsulfonyl, N—(C 1 -C 4 )-alkylaminocarbonyl, N—(C 3 -C 6 )-cycloalkylaminocarbonyl, N,N-di-(C 1 -C 4 )-alkylaminocarbonyl, N,N-di-(C 3 -C 6 )-cycloalkylaminocarbonyl, N,N—(C 3 -C 6 )-cycloalkyl-(C 1 -C 4 )-alkylaminocarbonyl, —CH═N—O—[(C 1 -C 4 )-alkyl], —CH═N—O—[(C 3 -C 6 )-cycloalkyl], —C[(C 1 -C 4 )-alkyl]=N—O—[(C 1 -C 4 )-alkyl], —C[(C 3 -C 6 )-cycloalkyl]=N—O—[(C 1 -C 4 )-alkyl], —C[(C 1 -C 4 )-alkyl]=N—O—[(C 3 -C 6 )-cycloalkyl], or —C[(C 3 -C 6 )-cycloalkyl]=N—O—[(C 3 -C 6 )-cycloalkyl],

R 6 represents hydrogen or optionally substituted (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-alkanoyl, or a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 7 represents hydrogen, or optionally substituted (C 1 -C 4 )-alkyl, or (C 3 -C 6 )-cycloalkyl, or, in the case that R 8 and R 9 do not form a ring closure, a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 8 represents hydrogen or represents optionally substituted (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, (C 3 -C 6 )-cycloalkyl, or together with R 6 or R 7 is closed in a ring formed by 1 to 3 CH 2 groups or together with R 9 is closed in 4- to 6-membered heterocyclic ring which, in the case of a 5- to 6-membered heterocyclic ring, may comprise further heteroatoms, and which is optionally mono- or polysubstituted by identical or different halogen substituents, cyano or by (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, or (C 1 -C 4 )-alkoxy, each of which is optionally mono- or polysubstituted by identical or different halogen substituents,

R 9 represents:

optionally substituted: (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, N-mono-(C 1 -C 4 )-alkylamino, N,N-di-(C 1 -C 4 )-alkylamino, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkylcarbonyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, or (C 1 -C 4 )-alkoxycarbonyl, in the case that R 7 represents hydrogen, or optionally substituted: (C 1 -C 4 )-alkyl, or (C 3 -C 6 )-cycloalkyl, or in the case that R 7 together with R 8 forms a 5- or 6-membered ring,

optionally substituted: (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, N-mono-(C 1 -C 4 )-alkylamino, N,N-di-(C 1 -C 4 )-alkylamino, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfinyl, or (C 1 -C 4 )-alkylsulfonyl, in the case that R 7 forms a 4-membered ring together with R 8 , or

R 8 and R 9 represent a 4- to 6-membered heterocyclic ring closure which, in the case of a 5- to 6-membered heterocyclic ring, may comprise further heteroatoms and is optionally mono- or polysubstituted by identical or different halogen substituents, cyano or by (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, or (C 1 -C 4 )-alkoxy, each of which is optionally mono- or polysubstituted by identical or different halogen substituents,

R 10 represents halogen, nitro, cyano, —SF 5 or represents phenyl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, thiophen-2-yl, thiophen-3-yl, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkenyl, (C 1 -C 4 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 3 -C 6 )-cycloalkylsulfanyl, (C 3 -C 6 )-cycloalkylsulfinyl, (C 3 -C 6 )-cycloalkylsulfonyl, —CH═N—O—[(C 1 -C 4 )-alkyl], or —C[(C 1 -C 4 )-alkyl]=N—O—[(C 1 -C 4 )-alkyl], optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, —SF 5 , (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, (C 1 -C 4 )-haloalkyl, (C 2 -C 4 )-haloalkenyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-haloalkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 3 -C 6 )-halocycloalkoxy, (C 3 -C 6 )-cyclo alkyl, (C 3 -C 6 )-halocycloalkyl, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 1 -C 4 )-haloalkylsulfonyl, (C 1 -C 4 )-haloalkylsulfanyl, (C 1 -C 4 )-haloalkylsulfinyl, (C 3 -C 6 )-cycloalkylsulfanyl, (C 3 -C 6 )-cycloalkylsulfinyl, (C 3 -C 6 )-cycloalkylsulfonyl, C 6 -,C 10 -,C 14 -aryl, C 6 -,C 10 -,C 14 -aryloxy, benzyl, benzyloxy, benzylthio, C 6 -,C 10 -,C 14 -arylthio, C 6 -,C 10 -,C 14 -arylamino, benzylamino, heterocyclyl, and trialkylsilyl, and

R 11 represents hydrogen, halogen, cyano or nitro or represents in each case optionally substituted (C 1 -C 4 )-alkyl, (C 3 -C 5 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, —CH═N—O—[(C 1 -C 4 )-alkyl], or —C[(C 1 -C 4 )-alkyl]=N—O—[(C 1 -C 4 )-alkyl],

and/or a

salt, metal complex, N-oxide and tautomeric form of the compound of formula (I),

with the proviso, that the compound 1-[4-(6-{2-[3-(chloromethyl)phenyl]ethyl}pyridin-3-yl)piperazin-1-yl]ethanone is excluded.

2. The compound according to claim 1 , wherein

Z represents optionally substituted naphthyl, dibenzo[b,d]furanyl, dibenzo[b,d]thiophenyl, indan-4-yl, benzothiophen-4-yl, benzofuran-4-yl, or indol-4-yl, or represents substituted phenyl of the substructure formula (II) and the phenyl of the substructure formula (II) carries no further substituents apart from R 10 and R 11 ,

Y represents O or S,

R 1 , R 2 , R 3 and R 4 each independently of one another represent a substituent selected from the group consisting of hydrogen, halogen, nitro, and cyano, or represent (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkoxycarbonyl, (C 3 -C 6 )-cycloalkoxycarbonyl, N-mono-(C 1 -C 4 )-alkylamino, N,N-di-(C 1 -C 4 )-alkylamino, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 3 -C 6 )-cycloalkylsulfanyl, (C 3 -C 6 )-cycloalkylsulfinyl, or (C 3 -C 6 )-cycloalkylsulfonyl, each of which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 3 -C 6 )-cycloalkyl, and (C 3 -C 6 )-halocycloalkyl,

R 6 represents hydrogen or represents (C 1 -C 4 )-alkyl, (C 3 -C 4 )-cycloalkyl, or (C 1 -C 4 )-alkanoyl, optionally mono- or polysubstituted by identical or different halogen substituents, or a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 7 represents hydrogen or represents (C 1 -C 4 )-alkyl, or (C 3 -C 4 )-cycloalkyl, optionally mono- or polysubstituted by identical or different halogen substituents, or, in the case that R 8 and R 9 do not form a ring closure, a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 8 represents hydrogen or represents (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, or (C 3 -C 4 )-cycloalkyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, nitro, and cyano, or a ring closure together with R 6 or R 7 formed by 1 to 3 CH 2 groups, or a 4- to 6-membered heterocyclic ring closure together with R 9 which, in the case of a 5- to 6-membered heterocyclic ring, may comprise further heteroatoms selected from the group consisting of N and O and which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl,

R 9 represents:

optionally substituted: (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 3 -C 4 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkylcarbonyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, or (C 1 -C 4 )-alkoxycarbonyl, each of which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, and (C 3 -C 6 )-cycloalkyl, in the case that R 7 represents hydrogen or (C 1 -C 4 )-alkyl, or (C 3 -C 4 )-cycloalkyl, optionally mono- or polysubstituted by identical or different halogen substituents, or in the case that R 7 with R 8 forms a 5- or 6-membered ring,

(C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 3 -C 4 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 3 -C 4 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfinyl, or (C 1 -C 4 )-alkylsulfonyl, in each case optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, and (C 3 -C 6 )-cycloalkyl, in the case that R 7 forms a 4-membered ring together with R 8 , or

R 8 and R 9 represent a 4- to 6-membered heterocyclic ring closure which, in the case of a 5- to 6-membered heterocyclic ring, may contain further heteroatoms selected from the group consisting of N and O, and which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl,

R 10 represents halogen or represents phenyl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, thiophen-2-yl, thiophen-3-yl, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkenyl, (C 1 -C 4 )-alkynyl, (C 3 -C 6 )-cyclo alkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 3 -C 6 )-cycloalkylsulfanyl, (C 3 -C 6 )-cycloalkylsulfinyl, (C 3 -C 6 )-cycloalkylsulfonyl, —CH═N—O—[(C 1 -C 4 )-alkyl], or —C[(C 1 -C 4 )-alkyl]=N—O—[(C 1 -C 4 )-alkyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 3 -C 6 )-cycloalkyl, and (C 3 -C 6 )-halocycloalkyl, and

R 11 represents hydrogen, halogen, cyano or nitro, or represents (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 3 -C 5 )-cycloalkyl, —CH═N—O—(C 1 -C 4 )-alkyl], or —C[(C 1 -C 4 )-alkyl]=N—O—[(C 1 -C 4 )-alkyl], optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, (C 1 -C 4 )-alkoxy, and (C 3 -C 6 )-cycloalkyl.

3. The compound according to claim 1 wherein

Z represents naphthyl, dibenzo[b,d]furanyl, dibenzo[b,d]thiophenyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-haloalkylsulfanyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-halocycloalkyl, (C 1 -C 4 )-alkylcarbonyl, and (C 1 -C 4 )-haloalkylcarbonyl, or Z represents substituted phenyl of the substructure formula (II),

at least one of the atoms A 3 or A 4 in the aromatic ring represents nitrogen,

R 1 , R 2 , R 3 and R 4 each independently of one another represent a substituent selected from the group consisting of hydrogen, halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-haloalkenyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-halocycloalkyl, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, and (C 1 -C 4 )-alkylsulfonyl,

R 6 represents hydrogen, (C 1 -C 4 )-alkyl or a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 7 represents hydrogen, (C 1 -C 4 )-alkyl, (C 3 -C 4 )-cycloalkyl or, in the case that R 8 and R 9 do not form a ring closure, a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 8 represents hydrogen or represents (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, or (C 3 -C 4 )-cycloalkyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and a ring closure together with R 6 or R 7 formed by 1 to 3 CH 2 groups, and a 4- to 6-membered heterocyclic ring closure together with R 9 which is formed by 3 to 5 CH 2 groups and which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl,

R 9 represents:

(C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-alkoxy, or (C 1 -C 6 )-alkylcarbonyl, each of which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, and (C 3 -C 6 )-cycloalkyl, in the case that R 7 represents hydrogen,

(C 1 -C 4 )-alkyl, or (C 3 -C 4 )-cycloalkyl, in the case that R 7 together with R 8 forms a 5- or 6-membered ring, or

(C 1 -C 4 )-alkyl, (C 3 -C 4 )-cycloalkyl, or (C 1 -C 4 )-alkoxy, each of which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, and (C 3 -C 6 )-cycloalkyl, in the case that R 7 together with R 8 forms a 4-membered ring, or

R 8 and R 9 represent a 4- to 6-membered heterocyclic ring closure which is formed by 3 to 5 CH 2 groups and which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl,

R 10 represents halogen or represents phenyl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, thiophen-2-yl, or thiophen-3-yl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, nitro, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 3 -C 6 )-cycloalkyl, and (C 3 -C 6 )-halocycloalkyl, or represents (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkenyl, (C 1 -C 4 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-alkoxy, (C 2 -C 4 )-alkenyloxy, (C 2 -C 4 )-alkynyloxy, (C 3 -C 6 )-cycloalkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, (C 3 -C 6 )-cycloalkylsulfanyl, (C 3 -C 6 )-cycloalkylsulfinyl, (C 3 -C 6 )-cycloalkylsulfonyl, —CH═N—O—[(C 1 -C 4 )-alkyl], or —C[(C 1 -C 4 )-alkyl]=N—O—[(C 1 -C 4 )-alkyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, and nitro, and

R 11 represents hydrogen, halogen, cyano or nitro or represents (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-alkylsulfinyl, (C 1 -C 4 )-alkylsulfonyl, or (C 3 -C 5 )-cycloalkyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, and (C 3 -C 6 )-cycloalkyl.

4. The compound according to claim 1 wherein

Z represents naphthyl, dibenzo[b,d]furanyl, dibenzo[b,d]thiophenyl, optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy, (C 1 -C 4 )-alkylsulfanyl, (C 1 -C 4 )-haloalkylsulfanyl, and (C 3 -C 6 )-cycloalkyl, or Z represents substituted phenyl of the substructure formula (II),

Y represents oxygen, and

X represents oxygen or —NR 6 .

5. The compound according to claim 1 wherein

Z represents naphthyl which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl, or represents unsubstituted dibenzo[b,d]furanyl or dibenzo[b,d]thiophenyl, or Z represents substituted phenyl of the substructure formula (II),

R 1 , R 2 , R 3 and R 4 represent a substituent selected from the group consisting of hydrogen, halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy and (C 1 -C 4 )-alkylsulfanyl,

R 6 represents hydrogen, (C 1 -C 3 )-alkyl, or a ring closure with R 8 formed by 1 to 2 CH 2 groups,

R 7 represents hydrogen or, in the case that R 8 and R 9 do not form a ring closure, a ring closure with R 8 formed by 1 to 3 CH 2 groups,

R 8 represents hydrogen or represents (C 1 -C 4 )-alkyl, optionally mono- or polysubstituted by identical or different halogen substituents, or a ring closure together with R 6 formed by 1 to 2 CH 2 groups or a ring closure together with R 7 formed by 1 to 3 CH 2 groups or a 4- to 6-membered heterocyclic ring closure together with R 9 which is formed by 3 to 5 CH 2 groups and which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl,

R 9 represents:

(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, or (C 1 -C 6 )-alkoxy, each of which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano and (C 3 -C 6 )-cycloalkyl, or

R 8 and R 9 represent a 4- to 6-membered heterocyclic ring closure which is formed by 3 to 5 CH 2 groups and which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, (C 1 -C 4 )-alkyl, and (C 1 -C 4 )-haloalkyl,

R 10 represents halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, or (C 1 -C 4 )-haloalkoxy or represents phenyl which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen, cyano, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy and (C 1 -C 4 )-haloalkoxy, and

R 11 represents hydrogen, halogen, nitro or cyano or represents (C 1 -C 4 )-alkyl, (C 3 -C 5 )-cycloalkyl, or (C 1 -C 4 )-alkoxy, optionally mono- or polysubstituted by identical or different halogen substituents.

6. The compound according to claim 1 wherein

Z represents a naphthyl of the substructure formula (III):

or represents unsubstituted dibenzo[b,d]furanyl or dibenzo[b,d]thiophenyl, or represents substituted phenyl of the substructure formula (II),

R 1 represents hydrogen, halogen, (C 1 -C 4 )-alkyl, or (C 1 -C 4 )-alkoxy,

R 2 represents hydrogen, halogen or (C 1 -C 4 )-haloalkyl,

R 3 represents hydrogen, halogen, (C 1 -C 4 )-alkoxy or (C 1 -C 4 )-alkylsulfanyl,

R 4 represents hydrogen or halogen,

R 6 represents hydrogen, or represents a piperazine ring closure with R 8 ,

R 7 represents hydrogen, or represents a pyrrolidine ring closure with R 8 ,

R 8 represents hydrogen, (C 1 -C 4 )-alkyl or represents a piperazine ring closure together with R 6 or represents a pyrrolidine ring closure together with R 7 or represents a piperidine ring closure together with R 9 ,

R 9 represents (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy, each of which is optionally mono- or polysubstituted by identical or different substituents from the group consisting of halogen and cyano, or

R 8 and R 9 represent a piperidine ring closure,

R 10 represents halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, or (C 1 -C 4 )-haloalkoxy or represents a phenyl of the substructure formula (IV):

R 11 represents hydrogen or halogen or represents (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy, optionally mono- or polysubstituted by identical or different halogen substituents,

R 12 , R 13 and R 14 each independently of one another represent hydrogen or halogen, and

R 15 represents hydrogen, halogen, cyano, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, or (C 1 -C 4 )-haloalkoxy.

7. The compound of claim 1 , wherein one and only one of the atoms A1, A2, A3 and A4 in the aromatic ring represents N.

8. The compound of claim 1 , wherein two and only two of the atoms A1, A2, A3 and A4 in the aromatic ring represents N.

9. A formulation comprising a compound according to claim 1 and at least one auxiliary.

10. The formulation according to claim 9 , additionally comprising a further agrochemical active compound.

11. A method of controlling one or more animal pests, comprising bringing a compound of formula (I) according to claim 1 or a formulation thereof into contact with the animal pests.

12. A product comprising a compound of formula (I) according to claim 1 or a formulation thereof for controlling one or more animal pests.

13. The product according to claim 12 , where the animal pests are mosquitoes.

14. A method of controlling one or more animal pests, comprising bringing a compound according to claim 1 or a formulation thereof into contact with a habitat of the animal pests.

15. A formulation comprising a compound according to claim 1 and at least one pharmaceutically acceptable excipient.

16. A method comprising treating a plant with a compound of formula (I) according to claim 1 or a formulation thereof.

17. A method comprising treating a seed with a compound of formula (I) according to claim 1 or a formulation thereof.

18. A method of controlling animal parasites, the method comprising treating an animal with an effective amount of a compound of formula (I) according to claim 1 or a formulation thereof.

19. The method of claim 18 , wherein the animal has an ectoparasitic infection.

20. The method of claim 18 , wherein the animal has an endoparasitic infection.

21. A product comprising a compound according to claim 1 or a formulation thereof for preparing one or more medicaments for controlling ectoparasites on animals.